Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 700 of 767

Advanced search

🇨🇭Nov 18Industryatinary.comTier 1 · Company source

Atinary and Chemspeed’s Demo Lab Opening

Atinary TechnologiesOriginal source

🌍Nov 18Mediaoxipit.aiTier 2 · Direct publisher

Diagnostikum Group selects Oxipit CXR Suite after rigorous multi-vendor evaluation

Oxipit (ChestLink for Thoracic X-ray/CT)Original source

🌍Nov 17Regulatoryravimiamet.eeTier 1 · Regulatory source

The Estonian Medicinal Products Market in the Third Quarter 2025

SAM EstoniaOriginal source

🌍Nov 17Industryoramed.comTier 1 · Company source

Oramed Reports Fiscal Third Quarter 2025 Financial Results

Oramed PharmaceuticalsOriginal source

🌍Nov 17Industryoramed.comTier 1 · Company source

ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS

Oramed PharmaceuticalsOriginal source

🇺🇰Nov 17Industryadaptimmune.comTier 1 · Company source

Adaptimmune Announces Changes to Board and Executive Leadership Team

AdaptimmuneOriginal source

🌍Nov 15Industrybenitec.comTier 1 · Company source

Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update

Benitec BiopharmaOriginal source

🌍Nov 15Deviceschembio.comTier 3 · Secondary coverage

CHEMBIO RECEIVES A GRANT FOR DEVELOPMENT OF A RAPID POINT OF CARE TEST FOR PREECLAMPSIA

Chembio Diagnostics, Inc.Original source

🇺🇸Nov 14Industrybeamtx.comTier 1 · Company source

Base Editing | Beam Therapeutics

Beam TherapeuticsOriginal source

🌍Nov 14Industrymyriad.comTier 3 · Secondary coverage

More Than Just Risk: Genetic Testing Is Shaping Breast Cancer Treatment

MyriadOriginal source

🇺🇸Nov 14Researcharchventure.comTier 2 · Direct publisher

Metsera acquired by Pfizer in $10 Billion deal to accelerate obesity drug development

ARCH Venture PartnersOriginal source

🌍Nov 14Industryuk-cpi.comTier 1 · Company source

New northern cluster aiming to shape UK’s bio-industrial future

CPI (Healthcare Innovation)Original source

🌍Nov 13Researchcatalystcr.comTier 2 · Direct publisher

Shaping the Future of Hematologic Oncology

Catalyst Clinical ResearchOriginal source

🇮🇱Nov 13Devicesmedinol.comTier 1 · Company source

First-in-Human Study of a Novel Left Atrial Pressure Sensor: The Microtech LVAD Study

MedinolOriginal source

🌍Nov 13Industryskyebioscience.comTier 1 · Company source

Third Quarter 2025 Financials & Operational Update

Skye BioscienceOriginal source

🌍Nov 13Researchnumerionlabs.aiTier 3 · Secondary coverage

Numerion Labs Publishes Breakthrough AI Research on Ultra-Fast Screening of Hyper-Scalable Virtual Libraries with NVIDIA

Numerion LabsOriginal source

🌍Nov 13Industryir.talphera.comTier 1 · Company source

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

TalpheraOriginal source

🇺🇸Nov 12Researchpodcasters.spotify.comTier 3 · Secondary coverage

“Collaborating with the entire history of human expression”

Lux CapitalOriginal source

🇨🇭Nov 12Industryalentis.chTier 1 · Company source

Alentis Strengthens Management Team with Key Appointments

Alentis TherapeuticsOriginal source

🇺🇸Nov 12CDMOveranex.comTier 2 · Direct publisher

Veranex Appoints Jose Pablo Morales, M.D. as Chief Medical Officer

VeranexOriginal source

🌍Nov 10Devicesdigitaldiagnostics.comTier 1 · Company source

Ophthalmic Innovation by the Decades: The 2010s

IDx (Digital Diagnostics)Original source

🌍Nov 10Devicesdigitaldiagnostics.comTier 1 · Company source

The Eye Exam Is Becoming An AI Exam

IDx (Digital Diagnostics)Original source

🇺🇸Nov 10Industrylighthorsetx.comTier 1 · Company source

Light Horse Therapeutics selected by the American Chemical Society as one of the 10 Start-ups to Watch

Light Horse TherapeuticsOriginal source

🌍Nov 10Industrymeridianbioscience.comTier 1 · Company source

Double Trouble: Viral Co-Infections and Their Role in Cancer Progression

Meridian BioscienceOriginal source

🌍Nov 8Industrybicara.comTier 1 · Company source

SITC 2025 Poster Presentation: Dual targeting of TGF-b and EGFR with ficerafusp alfa shows superior antitumor activity over cetuximab in KRAS/BRAF wild-type MSS colorectal cancer cell lines

Bicara TherapeuticsOriginal source

🇫🇷Nov 8Industrycellectis.comTier 1 · Company source

Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update

CellectisOriginal source

🌍Nov 8Industryskyebioscience.comTier 1 · Company source

ObesityWeek Presentation: Additional P2a Study Data

Skye BioscienceOriginal source

🌍Nov 7Industrycytomx.comTier 1 · Company source

Pharmacodynamic and Pharmacokinetic Activity of CX-801, a Masked IFNα2b PROBODY® Cytokine, in Patients with Advanced Melanoma

CytomX TherapeuticsOriginal source

🌍Nov 7Industrycytomx.comTier 1 · Company source

CX-908, a PROBODY® T Cell Engager Targeting CDH3 and CD3, Induces Tumor Regressions and Improves the Therapeutic Window in Preclinical Studies

CytomX TherapeuticsOriginal source

🌍Nov 7Industrymyriad.comTier 3 · Secondary coverage

One Visit. Lasting Impact. – A MyRisk® Provider Story

MyriadOriginal source

🌍Nov 6Industryrss.globenewswire.comTier 3 · Secondary coverage

GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates

GH ResearchOriginal source

🇨🇭Nov 5Industryatinary.comTier 1 · Company source

Atinary, ABB, Mettler-Toledo, and Agilent are building the first Self-Learning and Self-Driving Lab of its kind

Atinary TechnologiesOriginal source

🇺🇸Nov 5Researchpodcasters.spotify.comTier 3 · Secondary coverage

Europe, China and the future of open borders in science

Lux CapitalOriginal source

🌍Nov 5Industryuk-cpi.comTier 1 · Company source

CPI celebrates 10 years of biologics innovation in Darlington

CPI (Healthcare Innovation)Original source

🇳🇴Nov 5Researchuib.noTier 2 · Direct publisher

Millions in Research Funding for Fish Health at UiB

University of BergenOriginal source

🇫🇷Nov 5Researchpresse.inserm.frTier 2 · Direct publisher

Acute leukemia in children: exposure to certain air pollutants at birth could be associated with an increased risk

INSERMOriginal source

🇺🇸Nov 5Industrybeamtx.comTier 1 · Company source

Clinical Trials | Beam Therapeutics

Beam TherapeuticsOriginal source

🌍Nov 4Industrysubtlemedical.comTier 1 · Company source

Subtle Medical Enters UK Market to Drive Faster, Higher Quality MRI with SubtleHD™(MR)

Subtle MedicalOriginal source

🇺🇸Nov 4Industrybrukercellularanalysis.comTier 3 · Secondary coverage

Functional, Fast, and Unbiased TCR Discovery with Bruker’s Optofluidic Platform

Berkeley LightsOriginal source

🇫🇷Nov 3Industrycellectis.comTier 1 · Company source

Cellectis to Present a Development Update for eti-cel at ASH 2025

CellectisOriginal source

🌍Nov 3Researchcatalystcr.comTier 2 · Direct publisher

Biomarker-Driven Research: Transforming Treatments for Rare Cancers

Catalyst Clinical ResearchOriginal source

🌍Nov 3Industryintercure.coTier 1 · Company source

Form 6-K- Financial and operating results for the first half of 2025

InterCureOriginal source

🇫🇷Nov 1Industrycellectis.comTier 1 · Company source

Cellectis to Report Third Quarter Financial Results on November 7, 2025

CellectisOriginal source

🌍Nov 1Researchcatalystcr.comTier 2 · Direct publisher